Antithrombotic Drugs Market Size to grow by USD 21783.8 million between 2024-2028

Technavio, a leading provider of market research reports, has released its latest study on Antithrombotic Drugs Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges.

Key Highlights:

• Market Research Overview: The global pharmaceuticals market encompasses entities involved in the research and development (R&D) or manufacturing of various offerings, including generic and non-generic drugs, and veterinary medicines. According to Technavio's market analysis, the healthcare industry's total revenue is determined by the consolidated earnings of providers and manufacturers of medical equipment, pharmaceuticals, biotechnology, life sciences tools, and related services. Factors fueling the expansion of the pharmaceuticals sector include the growing aging population. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to surpass 60 years old. - The Antithrombotic Drugs Market is experiencing significant growth, fueled by the Growing prevalence of coagulation disorders. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

• Major Findings:
  • Growing prevalence of coagulation disorders
  • Introduction of novel oral anticoagulants
  • Strong side-effects of anticoagulants drugs
  • Availability of generics
• Growth Projections

The market size is estimated to grow by USD 21783.8 million, at a CAGR of 7.68% during the forecast period. The oral anticoagulant market faced stunted growth due to the prevalent concerns surrounding their adverse effects, including bruising, prolonged nosebleeds, and gastrointestinal bleeding. The absence of antidotes for novel oral anticoagulants further hindered market expansion. Antidotes are essential as they counteract the anticoagulant effects and enable the body to restore normal clotting function. The lack of these drugs posed a significant challenge for healthcare providers in managing excessive bleeding or mitigating side effects.

For insights on company offerings- Request a sample report!

• Regional Insights

The Antithrombotic Drugs Market represents a significant business opportunity due to the increasing prevalence of cardiovascular diseases and growing awareness of thrombosis prevention. Key players in this market include Daiichi Sankyo, Sanofi, and Bristol-Myers Squibb. These companies leverage innovative technologies and strategic collaborations to offer effective antithrombotic solutions, driving market growth. The market is expected to expand at a robust CAGR through 2027.

About Technavio                                                                        

Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies. 

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/